MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 421 to 440 of 166,322 approvalsPage 22 of 8317

Salbutamol Sulfate Injection

Approval Number: 国药准字H20254105
Registration: May 13, 2025
山东华鲁制药有限公司

Ketotifen Fumarate Oral Solution

Approval Number: 国药准字H20254155
Registration: May 13, 2025
海口天行健药物研究有限公司

Hydrocodone Bitartrate and Ibuprofen Tablets

Approval Number: 国药准字H20254119
Registration: May 13, 2025
宜昌人福药业有限责任公司

Biapenem for Injection and Sodium Chloride Injection

Approval Number: 国药准字H20254124
Registration: May 13, 2025
湖南科伦制药有限公司

Acetylcysteine Solution for Inhalation

Approval Number: 国药准字H20254128
Registration: May 13, 2025
海南皇隆制药股份有限公司

Fluvoxamine Maleate Tablets

Approval Number: 国药准字H20254176
Registration: May 13, 2025
苏州第三制药厂有限责任公司

Magnesium Sulfate Injection

Approval Number: 国药准字H20254117
Registration: May 13, 2025
江西博泰药业有限公司

Multiple Electrolytes, Sodium Acetate and Glucose Injection

Approval Number: 国药准字H20254088
Registration: May 13, 2025
仁合益康集团有限公司

Bireociclib Tablets

Approval Number: 国药准字H20250013
Registration: May 13, 2025
轩竹生物科技股份有限公司

Oxygen

Approval Number: 国药准字H20254098
Registration: May 13, 2025
侨源气体（眉山）有限公司

Tobramycin Eye Drops

Approval Number: 国药准字H20254153
Registration: May 13, 2025
浙江高跖医药科技股份有限公司

Methocarbamol Injection

Approval Number: 国药准字H20254112
Registration: May 13, 2025
海南普利制药股份有限公司

Desonide Cream

Approval Number: 国药准字H20254157
Registration: May 13, 2025
杭州领业医药科技有限公司

Flumazenil Injection

Approval Number: 国药准字H20254167
Registration: May 13, 2025
上海旭东海普药业有限公司

Neostigmine Methylsulfate Injection

Approval Number: 国药准字H20254141
Registration: May 13, 2025
云南先施药业有限公司

Iopromide Injection

Approval Number: 国药准字H20254086
Registration: May 13, 2025
博瑞制药（苏州）有限公司

Carbazochrome Sodium Sulfonate Injection

Approval Number: 国药准字H20254077
Registration: May 13, 2025
四川汇宇海玥医药科技有限公司

Diclofenac Sodium Sustained Release Tablets

Approval Number: 国药准字H20254097
Registration: May 13, 2025
锦州奥鸿药业有限责任公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.